Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, March 31, 2025.
MoonLake Immunotherapeutics - Class A Ordinary Shares (NASDAQ:MLTX)
Long-Term Downtrend (-90) - MLTX is in a strong downtrend that is likely to continue. While MLTX is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid MLTX?
MarketClub looks at technical strength and momentum to determine if the timing is right for MLTX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for MLTX
The long-term trend has been DOWN since Jan 13th, 2025 at 45.24
The intermediate-term trend has been DOWN since Dec 19th, 2024 at 50.60
The short-term trend has been DOWN since Mar 31st, 2025 at 38.28
Smart Scan Analysis for MLTX
Based on our trend formula, MLTX is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 39.0400 | 40.6850 | 37.2575 | 38.9800 | -0.8800 |
| Prev. Close | Volume | Bid | Ask | Time |
| 39.8600 | 598368 | 2025-03-31 15:59:38 |
| 52wk High | 58.26 | 52wk High Date | 2024-12-17 |
| 52wk Low | 36.52 | 52wk Low Date | 2025-03-11 |
| Average Volume | 428,835 | Shares Outstanding | 63,283 |
| Assets | 477,933,282M | Liabilities | 31,108,280M |
| P/E Ratio | -39.51610000 |